Safety and Efficacy Study of Ramelteon in Subjects With Chronic Insomnia

Status:
Completed

Trial end date:
2008-03-01

Target enrollment:

Participant gender:

The purpose of this study is to determine the safety and efficacy of 4 mg of Ramelteon, once daily (QD), in subjects with chronic insomnia.

Phase 3

Takeda